Introduction
aSAH is a significant cause of morbidity and mortality, therefore early aneurysm repair treatment, surgical clipping or endovascular coiling, is mandatory to reduce the rate of rebleeding. Determination of treatment should be a multidisciplinary decision based on characteristics of the patient and the aneurysm, however there is variability among the different centers.
Objectives
Analysis of outcomes and complications in patients with aSAH in regard to election of repair treatment modality and short term therapy.
Methods
Multicenter, prospective and observational study. Including aSAH patients admitted in five neurocritical care units over 2014. Different variables were analized: morbidity (GOS at discharge), aneurysm location and size, repair treatment, aneurysm obliteration time, complications, ICU and hospital lenght of stay.
Results
Sample size: 88 patients. Repair treatment: surgical(S) 28,41%, endovascular (EVT) 56,82% and conservative 14,77%. Morbidity-GOS scale (S/EVT): 1 = 8 % /14 %; 2 = 4 %/ 2%; 3 =12 % /12 % 4: 28%/ 14% 5: 48 %/ 58% (p 0,59). We separated 2 GOS groups: good prognosis 
Conclusions
EVT grows up in the analyzed centers. In this study differences about outcomes and complications are not found in regard to repair treatment. In surgical patients rebleeding increases and in EVT DCI is greater. Short term therapy (< 72 h) decreases rebleeding. There is statistical significance in lenght of stay (ICU and hospital) decreases in EVT patients. 
